Fall risk in rheumatoid arthritis revisited: A follow-up study focusing on sarcopenia and glucocorticoid use

Naoki Nakagawa, Keita Nagira, Masako Hayashibara, Takashi Wada, Yuki Kitsuda, Yuta Takasu, Chikako Takeda, Mari Osaki, Hiroshi Hagino, Hideki Nagashima · 2026

Read Fall risk in rheumatoid arthritis revisited: A follow-up study focusing on sarcopenia and glucocorticoid use by Naoki Nakagawa, Keita Nagira, Masako Hayashibara, Takashi Wada, Yuki Kitsuda, Yuta Takasu, Chikako Takeda, Mari Osaki, Hiroshi Hagino, Hideki Nagashima (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13650162.txt.

Description

Nakagawa and co-authors revisit fall risk in women with rheumatoid arthritis, a joint disease that erodes bone and muscle. The team followed 124 walking patients aged fifty and over at one center in 2022 and 2023. Falls were counted over a full year.

The yearly fall rate fell to about twenty-seven percent, far below the fifty percent of their earlier group. A past history of falls more than doubled the odds of falling again. The study weighs two factors in depth: loss of muscle mass and use of steroid drugs. Their interplay was tested with careful statistics. Falls break bones and independence in this group, so sharp risk signs matter. The drop in falls may reflect better modern care.

Catalog record

CREATORNaoki Nakagawa, Keita Nagira, Masako Hayashibara, Takashi Wada, Yuki Kitsuda, Yuta Takasu, Chikako Takeda, Mari Osaki, Hiroshi Hagino, Hideki Nagashima
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE33 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC13650162

Browse the full library · About the Tower of Babel